Iribarren C - Search Results

1

Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease.

Hsu CY, Go AS, McCulloch CE, Darbinian J, Iribarren C. Hsu CY, et al. Among authors: iribarren c. Clin J Am Soc Nephrol. 2007 Jan;2(1):81-8. doi: 10.2215/CJN.01950606. Epub 2006 Nov 29. Clin J Am Soc Nephrol. 2007. PMID: 17699391

2

Cohort study of exposure to environmental tobacco smoke and risk of first ischemic stroke and transient ischemic attack.

Iribarren C, Darbinian J, Klatsky AL, Friedman GD. Iribarren C, et al. Neuroepidemiology. 2004 Jan-Apr;23(1-2):38-44. doi: 10.1159/000073973. Neuroepidemiology. 2004. PMID: 14739566

3

Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults: the CARDIA study.

Iribarren C, Gross MD, Darbinian JA, Jacobs DR Jr, Sidney S, Loria CM. Iribarren C, et al. Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):216-21. doi: 10.1161/01.ATV.0000148322.89911.44. Epub 2004 Oct 21. Arterioscler Thromb Vasc Biol. 2005. PMID: 15499045

4

Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.

Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Hsu CY, et al. Among authors: iribarren c. Arch Intern Med. 2005 Apr 25;165(8):923-8. doi: 10.1001/archinte.165.8.923. Arch Intern Med. 2005. PMID: 15851645

5

The conundrum of increased burden of end-stage renal disease in Asians.

Hall YN, Hsu CY, Iribarren C, Darbinian J, McCulloch CE, Go AS. Hall YN, et al. Among authors: iribarren c. Kidney Int. 2005 Nov;68(5):2310-6. doi: 10.1111/j.1523-1755.2005.00691.x. Kidney Int. 2005. PMID: 16221234 Free article.

6

Body mass index and risk for end-stage renal disease.

Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Hsu CY, et al. Among authors: iribarren c. Ann Intern Med. 2006 Jan 3;144(1):21-8. doi: 10.7326/0003-4819-144-1-200601030-00006. Ann Intern Med. 2006. PMID: 16389251

7

Statin and beta-blocker therapy and the initial presentation of coronary heart disease.

Go AS, Iribarren C, Chandra M, Lathon PV, Fortmann SP, Quertermous T, Hlatky MA; Atherosclerotic Disease, Vascular Function and Genetic Epidemiology (ADVANCE) Study. Go AS, et al. Among authors: iribarren c. Ann Intern Med. 2006 Feb 21;144(4):229-38. doi: 10.7326/0003-4819-144-4-200602210-00004. Ann Intern Med. 2006. PMID: 16490908

8

Does the association between serum endostatin, an endogenous anti-angiogenic protein, and acute myocardial infarction differ by race?

Iribarren C, Herrinton LJ, Darbinian JA, Tamarkin L, Malinowski D, Vogelman JH, Orentreich N, Baer D. Iribarren C, et al. Vasc Med. 2006 Feb;11(1):13-20. doi: 10.1191/1358863x06vm654oa. Vasc Med. 2006. PMID: 16669408

9

Validation of a new brief physical activity survey among men and women aged 60-69 years.

Taylor-Piliae RE, Norton LC, Haskell WL, Mahbouda MH, Fair JM, Iribarren C, Hlatky MA, Go AS, Fortmann SP. Taylor-Piliae RE, et al. Among authors: iribarren c. Am J Epidemiol. 2006 Sep 15;164(6):598-606. doi: 10.1093/aje/kwj248. Epub 2006 Jul 13. Am J Epidemiol. 2006. PMID: 16840522

10

Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population.

Iribarren C, Darbinian JA, Lo JC, Fireman BH, Go AS. Iribarren C, et al. Am J Epidemiol. 2006 Dec 15;164(12):1150-9. doi: 10.1093/aje/kwj341. Epub 2006 Oct 13. Am J Epidemiol. 2006. PMID: 17041127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters